Related references
Note: Only part of the references are listed.Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis A Randomized Trial
Joel Kremer et al.
ANNALS OF INTERNAL MEDICINE (2013)
HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab
Hennie G. Raterman et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks
Xin-Min Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Tofacitinib (CP-690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve-month data from a twenty-fourmonth phase III randomized radiographic study
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2013)
Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial
Gerd R. Burmester et al.
LANCET (2013)
Proteomic profiling following immunoaffinity capture of high-density lipoprotein: Association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis
Junji Watanabe et al.
ARTHRITIS AND RHEUMATISM (2012)
Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
Roy Fleischmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy
Jeffrey R. Curtis et al.
ARTHRITIS CARE & RESEARCH (2012)
Measurement of Reverse Cholesterol Transport Pathways in Humans: In Vivo Rates of Free Cholesterol Efflux, Esterification, and Excretion
Scott Turner et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
George D. Kitas et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study
A. Jamnitski et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis
Debra M. Meyer et al.
JOURNAL OF INFLAMMATION-LONDON (2010)
Lipoprotein Subclasses Determined by Nuclear Magnetic Resonance Spectroscopy and Coronary Atherosclerosis in Patients with Rheumatoid Arthritis
Cecilia P. Chung et al.
JOURNAL OF RHEUMATOLOGY (2010)
Abnormal Function of High-Density Lipoprotein Is Associated With Poor Disease Control and an Altered Protein Cargo in Rheumatoid Arthritis
Christina Charles-Schoeman et al.
ARTHRITIS AND RHEUMATISM (2009)
Atherogenic lipoprotein phenotype and LDL size and subclasses in drug-naive patients with early rheumatoid arthritis
Manfredi Rizzo et al.
ATHEROSCLEROSIS (2009)
Atheroprotective Effects of Methotrexate on Reverse Cholesterol Transport Proteins and Foam Cell Transformation in Human THP-1 Monocyte/Macrophages
Allison B. Reiss et al.
ARTHRITIS AND RHEUMATISM (2008)
HDL cholesterol transport during inflammation
Deneys R. van der Westhuyzen et al.
CURRENT OPINION IN LIPIDOLOGY (2007)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis - A population-based cohort study
H Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
BJ Ansell et al.
CIRCULATION (2003)
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis
M Boers et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers
LC Hudgins et al.
JOURNAL OF LIPID RESEARCH (2003)
HDL and the inflammatory response induced by LDL-derived oxidized phospholipids
M Navab et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Share Paper
